File Download
 
 
Supplementary

Postgraduate Thesis: Dysregulated PAK4 and chemosensitivity in ovarian cancer: an in vitro study
  • Basic View
  • Metadata View
  • XML View
TitleDysregulated PAK4 and chemosensitivity in ovarian cancer: an in vitro study
 
AuthorsChu, Chun-ho, Terence.
朱雋皞.
 
Issue Date2012
 
PublisherThe University of Hong Kong (Pokfulam, Hong Kong)
 
AbstractOvarian cancer is regarded as the most lethal gynecological malignancy around the world. Despite the advancing medical improvements in both surgery and chemotherapy, the mortality rate did not appear to be reduced. This could be account for the late diagnosis of ovarian cancer until advanced stage. Recently, p-21 activated kinase 4 (PAK4), as a potential significant prognostic marker of ovarian cancer, has been widely studied on its contribution in oncogenesis properties. It was suggested that PAK4 proteins were activated and confer chemoresistance in ovarian cancers. In this study, we hypothesized that the up-regulation of PAK4 in ovarian cancers maybe resulted from mutations and amplification in genomic DNA level. Investigations on PAK4 genetic alterations were carried out. Recurrent mutations were found in the kinase domain of PAK4 in three ovarian cancer cell lines and two clinical samples. Single mutation was found in the exon 3 of PAK4 coding for GTPase binding domain (GTB). Amplifications of PAK4 genomic DNA were also found in four ovarian cancer cell lines. On top of that, dysregulated PAK4 level in chemosensitivity ovarian cancer cell line, A2780s showed PAK4 contribution in protection against apoptosis. Meanwhile PAK4 transfected chemoresistance cell line A2780cp also showed similar effect to PAK4 transfected A2780s. Kinase-dead and constitutively active PAK4 did not show any significance contribution to the apoptosis property. This may suggest that PAK4 do not operate all kinase domains towards apoptotic function. Immortalized normal ovarian epithelial cell line, HOSE6-3 was also upregulated with PAK4 transfection. However it did not induce the oncogenesis property of cell survival.
 
DegreeMaster of Medical Sciences
 
SubjectProtein kinases.
Ovaries - Cancer.
 
Dept/ProgramPathology
 
DC FieldValue
dc.contributor.authorChu, Chun-ho, Terence.
 
dc.contributor.author朱雋皞.
 
dc.date.hkucongregation2012
 
dc.date.issued2012
 
dc.description.abstractOvarian cancer is regarded as the most lethal gynecological malignancy around the world. Despite the advancing medical improvements in both surgery and chemotherapy, the mortality rate did not appear to be reduced. This could be account for the late diagnosis of ovarian cancer until advanced stage. Recently, p-21 activated kinase 4 (PAK4), as a potential significant prognostic marker of ovarian cancer, has been widely studied on its contribution in oncogenesis properties. It was suggested that PAK4 proteins were activated and confer chemoresistance in ovarian cancers. In this study, we hypothesized that the up-regulation of PAK4 in ovarian cancers maybe resulted from mutations and amplification in genomic DNA level. Investigations on PAK4 genetic alterations were carried out. Recurrent mutations were found in the kinase domain of PAK4 in three ovarian cancer cell lines and two clinical samples. Single mutation was found in the exon 3 of PAK4 coding for GTPase binding domain (GTB). Amplifications of PAK4 genomic DNA were also found in four ovarian cancer cell lines. On top of that, dysregulated PAK4 level in chemosensitivity ovarian cancer cell line, A2780s showed PAK4 contribution in protection against apoptosis. Meanwhile PAK4 transfected chemoresistance cell line A2780cp also showed similar effect to PAK4 transfected A2780s. Kinase-dead and constitutively active PAK4 did not show any significance contribution to the apoptosis property. This may suggest that PAK4 do not operate all kinase domains towards apoptotic function. Immortalized normal ovarian epithelial cell line, HOSE6-3 was also upregulated with PAK4 transfection. However it did not induce the oncogenesis property of cell survival.
 
dc.description.naturepublished_or_final_version
 
dc.description.thesisdisciplinePathology
 
dc.description.thesislevelmaster's
 
dc.description.thesisnameMaster of Medical Sciences
 
dc.identifier.hkulb4827399
 
dc.languageeng
 
dc.publisherThe University of Hong Kong (Pokfulam, Hong Kong)
 
dc.relation.ispartofHKU Theses Online (HKUTO)
 
dc.rightsThe author retains all proprietary rights, (such as patent rights) and the right to use in future works.
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.source.urihttp://hub.hku.hk/bib/B48273995
 
dc.subject.lcshProtein kinases.
 
dc.subject.lcshOvaries - Cancer.
 
dc.titleDysregulated PAK4 and chemosensitivity in ovarian cancer: an in vitro study
 
dc.typePG_Thesis
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Chu, Chun-ho, Terence.</contributor.author>
<contributor.author>&#26417;&#38603;&#30366;.</contributor.author>
<date.issued>2012</date.issued>
<description.abstract>&#65279;Ovarian cancer is regarded as the most lethal gynecological malignancy around the

world. Despite the advancing medical improvements in both surgery and

chemotherapy, the mortality rate did not appear to be reduced. This could be

account for the late diagnosis of ovarian cancer until advanced stage. Recently, p-21

activated kinase 4 (PAK4), as a potential significant prognostic marker of ovarian

cancer, has been widely studied on its contribution in oncogenesis properties. It was

suggested that PAK4 proteins were activated and confer chemoresistance in ovarian

cancers.

In this study, we hypothesized that the up-regulation of PAK4 in ovarian cancers

maybe resulted from mutations and amplification in genomic DNA level.

Investigations on PAK4 genetic alterations were carried out. Recurrent mutations

were found in the kinase domain of PAK4 in three ovarian cancer cell lines and two

clinical samples. Single mutation was found in the exon 3 of PAK4 coding for

GTPase binding domain (GTB). Amplifications of PAK4 genomic DNA were also

found in four ovarian cancer cell lines.

On top of that, dysregulated PAK4 level in chemosensitivity ovarian cancer cell line,

A2780s showed PAK4 contribution in protection against apoptosis. Meanwhile

PAK4 transfected chemoresistance cell line A2780cp also showed similar effect to

PAK4 transfected A2780s. Kinase-dead and constitutively active PAK4 did not

show any significance contribution to the apoptosis property. This may suggest that

PAK4 do not operate all kinase domains towards apoptotic function. Immortalized

normal ovarian epithelial cell line, HOSE6-3 was also upregulated with PAK4

transfection. However it did not induce the oncogenesis property of cell survival.</description.abstract>
<language>eng</language>
<publisher>The University of Hong Kong (Pokfulam, Hong Kong)</publisher>
<relation.ispartof>HKU Theses Online (HKUTO)</relation.ispartof>
<rights>The author retains all proprietary rights, (such as patent rights) and the right to use in future works.</rights>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<source.uri>http://hub.hku.hk/bib/B48273995</source.uri>
<subject.lcsh>Protein kinases.</subject.lcsh>
<subject.lcsh>Ovaries - Cancer.</subject.lcsh>
<title>Dysregulated PAK4 and chemosensitivity in ovarian cancer: an in vitro study</title>
<type>PG_Thesis</type>
<identifier.hkul>b4827399</identifier.hkul>
<description.thesisname>Master of Medical Sciences</description.thesisname>
<description.thesislevel>master&apos;s</description.thesislevel>
<description.thesisdiscipline>Pathology</description.thesisdiscipline>
<description.nature>published_or_final_version</description.nature>
<date.hkucongregation>2012</date.hkucongregation>
<bitstream.url>http://hub.hku.hk/bitstream/10722/173867/1/FullText.pdf</bitstream.url>
</item>